Cantitate/Preț
Produs
Total produse
Vezi coșul
Statins: The HMG CoA reductase inhibitors in perspective de Allan Gaw MD PhD

Statins: The HMG CoA reductase inhibitors in perspective

Editat de Allan Gaw MD PhD, Christopher J Packard MRCPath DSc, James Shepherd MB ChB PhD FRCPath FRCP(Glasg)
en Limba Engleză Hardback – 4 dec 2003
What is a statin? It is the most powerful lipid-lowering agent yet produced. Its main action is to lower the low-density lipoprotein (LDL) cholesterol level, thereby reducing the overall cholesterol level in the blood. In this new edition of this popular book, the authors examine the existing and emerging statins and their beneficial effectiveness in reducing serum cholesterol. New chapters cover combination therapy in lipid-lowering, new 'Megatrials' (HPS and PPP) and the PROSPER study. Also presented are the effects of statins on non-vascular conditions such as osteoporosis, cancer, dementia and diabetes.
Citește tot Restrânge

Preț: 63712 lei

Preț vechi: 76846 lei
-17% Nou

Puncte Express: 956
Preț estimativ în valută:
12193€ • 12666$ • 10128£

Carte tipărită la comandă

Livrare economică 01-15 februarie 25

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781841842929
ISBN-10: 1841842923
Pagini: 262
Ilustrații: 20 black & white tables
Dimensiuni: 189 x 246 x 20 mm
Greutate: 0.92 kg
Ediția:Revizuită
Editura: CRC Press
Colecția CRC Press
Locul publicării:United Kingdom

Public țintă

Professional

Cuprins

1. Hyperlipidaemia as a Risk Factor for Coronary Heart Disease 2. Lipid Control in the Pre-Statin Era 3. The Discovery and Development of the Statins 4. Comparative Chemistry, Pharmacology and the Mechanism of Action of the Statins 5. Ancillary Benefits of the Statins 6. Angiographic and IVUS Techniques Evaluating Progression and Regression of Coronary Atherosclerosis: Statin Intervention Trials in Perspective 7. The Scandanavian Simvastatin Survival Study (4S) 8. Primary Prevention of Coronary Heart Disease with Statins 9. The CARE (Cholesterol and Recurrent Events) Trial: The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels 10. The LIPID (Long-term Intervention with Pravastatin in Ischemic Disease) Study: Results and Implications for Clinical Practice 11. Mega-trials: the Prospective Pravastatin Pooling Project (PPP) and the Heart Protection Study (HPS) 12. The Prospective Study of Pravastatin in the Elderly at Risk (PROSPER) 13. Combination Therapy with Statins 14. Guidelines for Clinical Use of the Statins 15. The Cost-effectiveness of Statin Use 16. Unanswered Questions About the Use of Statins 17. Statin Therapy for the 21st Century

Notă biografică

Allan Gaw MD PhD, Christopher J. Packard MRCPath DSc, James hepherd MB ChB PhD FRCPath FRCP(Glasg),

Descriere

In the new edition of this popular book, the authors examine the existing and emerging statins and their beneficial effectiveness in reducing serum cholesterol.